| Literature DB >> 32316595 |
Jin Young Yoo1, Hyun Jeong Cho1, Sungji Moon2,3,4, Jeoungbin Choi2,5, Sangjun Lee2,3,5, Choonghyun Ahn2,3,5, Keun-Young Yoo2, Inah Kim6, Kwang-Pil Ko7, Jung Eun Lee1,8, Sue K Park2,3,5.
Abstract
An increased risk of gastric cancer for pickled vegetable and salted fish intake has been suggested, yet the lack of a dose-response association warrants a quantitative analysis. We conducted a meta-analysis, combining results from our analysis of two large Korean cohort studies and those from previous prospective cohort studies. We investigated the association of pickled vegetable and salted fish intake with gastric cancer in the Korean Genome Epidemiology Study and the Korean Multi-center Cancer Cohort Study using Cox proportional hazard models. We then searched for observational studies published until November 2019 and conducted both dose-response and categorical meta-analyses. The pooled relative risk (RR) of gastric cancer incidence was 1.15 (95% Confidence Interval (CI), 1.07-1.23) for 40 g/day increment in pickled vegetable intake in a dose-response manner (P for nonlinearity = 0.11). As for salted fish intake, the pooled risk of gastric cancer incidence was 1.17 (95% CI, 0.99-1.38) times higher, comparing the highest to the lowest intake. Our findings supported the evidence that high intake of pickled vegetable and salted fish is associated with elevated risk of gastric cancer incidence.Entities:
Keywords: gastric cancer; meta-analysis; pickled vegetable; salted fish
Year: 2020 PMID: 32316595 PMCID: PMC7225928 DOI: 10.3390/cancers12040996
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639
Relative risks (95% confidence intervals) of gastric cancer risk according to pickled vegetable or salted fish intake in the Korean cohort studies.
|
|
|
|
| ||||||
|
|
|
|
|
| |||||
|
| |||||||||
|
| |||||||||
| Case no. | 15 | 15 | 18 | 21 | 12 | 81 | |||
| Person-years | 9153.04 | 8983.91 | 9774.26 | 11020.96 | 7474.97 | 46407.13 | |||
| Model 1 a | 1.00 (reference) | 0.96 (0.47–1.97) | 1.19 (0.60–2.37) | 1.09 (0.56–2.12) | 0.93 (0.44–1.99) | 0.98 | 0.95 (0.80–1.13) | ||
| Model 2 b | 1.00 (reference) | 0.99 (0.48–2.03) | 1.21 (0.60–2.40) | 1.10 (0.56–2.15) | 0.95 (0.44–2.04) | 0.97 | 0.95 (0.80–1.13) | ||
|
| |||||||||
|
| |||||||||
| Case no. | 35 | 34 | 31 | 49 | 50 | 199 | |||
| Person-years | 280471.68 | 282869.54 | 283603.52 | 289748.48 | 314506.54 | 1451199.76 | |||
| Model 1 c | 1.00 (reference) | 0.84 (0.52–1.35) | 0.79 (0.49–1.29) | 1.14 (0.73–1.77) | 0.89 (0.57–1.40) | 0.99 | 0.99 (0.95–1.03) | ||
| Model 2 d | 1.00 (reference) | 0.83 (0.52–1.33) | 0.79 (0.49–1.28) | 1.14 (0.73–1.77) | 0.85 (0.54–1.34) | 0.84 | 0.99 (0.95–1.03) | ||
|
|
|
|
| ||||||
|
|
|
| |||||||
|
| |||||||||
|
| |||||||||
| Case no. | 88 | 113 | 95 | 296 | |||||
| Person-years | 45481.01 | 53529.26 | 46630.12 | 145640.40 | |||||
| Model 1a | 1.00 (reference) | 1.15 (0.87–1.53) | 1.08 (0.80–1.44) | 0.85 | 1.10 (0.70–1.73) | ||||
| Model 2b | 1.00 (reference) | 1.05 (0.78–1.40) | 1.03 (0.77–1.38) | 0.94 | 1.01 (0.63–1.61) | ||||
|
| |||||||||
|
| |||||||||
| Case no. | 22 | 42 | 26 | 90 | |||||
| Person-years | 45690.51 | 53829.00 | 46943.62 | 146463.13 | |||||
| Model 1 a | 1.00 (reference) | 1.74 (1.03–1.93) | 1.26 (0.71–1.24) | 0.93 | 1.50 (0.69–3.23) | ||||
| Model 2 b | 1.00 (reference) | 1.39 (0.81–1.38) | 1.12 (0.63–1.00) | 0.91 | 1.22 (0.54–2.78) | ||||
|
| |||||||||
| Case no. | 72 | 62 | 67 | 201 | |||||
| Person-years | 491079.82 | 465063.62 | 502876.12 | 1459019.56 | |||||
| Model 1 c | 1.00 (reference) | 1.03 (0.73–1.45) | 0.90 (0.64–1.27) | 0.48 | 1.89 (0.37–9.70) | ||||
| Model 2 d | 1.00 (reference) | 1.03 (0.73–1.45) | 0.86 (0.61–1.22) | 0.32 | 1.40 (0.26–7.52) | ||||
|
| |||||||||
| MV adjusted | 1.00 (reference) | 1.12 (0.84–1.50) | 0.92 (0.68–1.24) | 0.80 | 1.25 (0.60–2.62) | ||||
Abbreviations: KMCC, Korean Multi-center Cancer Cohort; KoGES, Korean Genome Epidemiology Study; CAVAS, Cardiovascular Disease Association Study; HEXA, Health Examinee; BMI, Body Mass Index; MV, Multivariate. a Model 1: Stratified by age (20 to < 50, 50 to < 60, 60 to < 70, and 70+ years) and adjusted for age at baseline (continuous, years) and sex. b Model 2: Model 1 further adjusted for survey year (continuous, year), BMI (10 to < 18.5, 18.5 to < 23, 23 to < 25, 25 to < 30, and 30+ kg/m2 for analysis of incidence and 10 to < 23, 23 to < 25, and 25+ kg/m2 for analysis of mortality), smoking status (never smoker, past smoker, and current smoker), and alcohol drinking frequency (never, 0 < to < 1 time per week, 1 time per week to < 3 times per week, 3 times per week to <1 time per day, and 1+ time per day) c Model 1: Stratified by age (40 to < 50, 50 to < 60, and 60+ years) and study cohort (the Ansan and Ansung study, the CAVAS, and the HEXA study) and further adjusted for age at baseline (continuous, year), sex, and total energy intake (continuous, kcal/day).d Model 2: Model 1 further adjusted for survey year (continuous, year), BMI (10 to < 18.5, 18.5 to < 23, 23 to < 25, 25 to < 30, and 30+ kg/m2), smoking status (0, 0 < to < 10, 10 to < 20, and 20+ pack-years), and alcohol intake (0, 0 < to < 5, 5 to < 15, 15 to < 30, and 30+ g/day).
Figure 1Flow diagram of study selection for meta-analysis. a Botterweck et al. [32]; b Kneller RW et al. [33]; c Sjodahl K et al. [34] and Kneller RW et al. [33].
Characteristics of studies included in the meta-analysis.
| First Author, Year | Study | Country | Recruitment Period/Follow-up Period | Exposure Assessment | Exposure | Outcome | Cases/total Participants | Adjusted Variables |
|---|---|---|---|---|---|---|---|---|
| Nomura A et al., 1990 [ | Honolulu Hearth Program (HHP) | US (Japanese ancestry) | 1965–1968/ Average 10.6 years | 20-item FFQ | Pickles | Incidence | 150/7990 | Age |
| Kneller RW et al., 1991 [ | Lutheran Brotherhood Insurance Society (LBS) | US | 1966/20 years | 35-item FFQ | Salted fish | Mortality | 72/17,633 | Year of birth and current cigarette smoking |
| Kato I et al., 1992 [ | Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) | Japan | 1985–1989/4.4 years | 10-item questionnaire | Pickles | Incidence | 45/3914 | Sex, age, and residence |
| Kato I et al., 1992 [ | Higashi-Kamo Cohort | Japan | 1985/ Until 1991 | 25-item questionnaire | Pickles | Mortality | 57/9753 | Age and sex |
| Inoue M et al., 1996 [ | Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) | Japan | 1985–1989/ Until 1995 | FFQ | Pickled vegetables, salted or dried fish | Incidence | 69/5373 | Gender and age |
| Galanis DJ et al., 1998 [ | Hawaii Department of Health Survey | US (Japanese ancestry) | 1975–1980/14.8 years | FFQ | Pickled vegetables, dried or salted fish | Incidence | 108/11,907 | Age, years of education, Japanese place of birth, and gender (in combined analysis) |
| Knekt P et al., 1999 [ | Finnish Mobile Clinic Health Examination Survey (FMCHES) | Finland | 1966–1972/24 years | Dietary history interview | Smoked and salted fish | Incidence | 68/9985 | Sex, age, municipality, smoking, and energy intake |
| Ngoan LT et al., 2002 [ | Miyako Study | Japan | 1986–1989/ Until 1999 | 25-item FFQ | Pickled food, processed fish | Mortality | 59/7483 | Age, sex, smoking, processed meat, liver, cooking or salad oil, suimono |
| Khan MMH et al., 2004 [ | Hokkaido Cohort | Japan | 1984–1985/ Until 2002 | FFQ | Japanese pickle, salty fish | Mortality | 51/3158 | Men: |
| Tsugane S et al., 2004 [ | The Japan Public Health Center-based prospective Study (JPHC I and II) | Japan | 1990/ Until 2001 | FFQ | Pickled vegetables, dried or salted fish | Incidence | 486/39,065 | Age in 1990, cigarette smoking, and fruit and non-green-yellow vegetable intake, quartile categories of salt intake, and stratified by PHC area |
| Wong B et al., 2004 [ | Changle County Helicobacter Trial (CCHT) | China | 1994/ Until 2002 | FFQ | Preserved vegetables, salty fish | Incidence | 18/1630 | N/A |
| Sauvaget C et al., 2005 [ | Radiation Effects Research Foundation (RERF) | Japan | Men: 1978–1980; Women: 19781981–/20 years | 22-item FFQ | Pickles | Incidence | 1270/ 38,576 | Age, sex, |
| Iso H et al., 2007 [ | The Japan Collaborative Cohort Study (JACC) | Japan | 1988–1990/ Until 2003 | FFQ | Pickles, dried or salted fish | Mortality | 1076/ 101,190 | Age and area of study |
| Takachi R et al., 2010 [ | The Japan Public Health Center-based prospective Study (JPHC I and II) | Japan | 1990 (JPHC I); | 138-item FFQ | Pickled vegetables, dried and salted fish | Incidence | 876/77,500 | Sex, age, BMI, smoking status, alcohol consumption, physical activity in metabolic equivalent task-hours/d, and quintiles of energy, potassium, and calcium |
| Tran GD et al., 2005 [ | Linxian General Population Trial Cohort (NIT) | China | 1984/ Until 2001 | 9-item FFQ | Pickled vegetables | Incidence (gastric cardia cancer) | 1089/29,584 | Age and gender |
| Incidence (gastric non-cardia cancer) | 363/29,584 |
Abbreviation: FFQ, Food Frequency Questionnaire. a Studies included in both dose-response and categorical meta-analysis. b Studies included in categorical meta-analysis only. c Studies included in dose-response meta-analysis only. d Study included instead of Takachi R et al. [47] when conducting subgroup analysis by sex.
Figure 2Study-specific and combined relative risks (95% confidence intervals) of gastric cancer incidence (a) per 40 g/day increment in pickled vegetable intake and (b) comparing the highest to the lowest intake of pickled vegetables; Abbreviation: GC, Gastric Cancer; GCC, Gastric Cardia Cancer; GNCC, Gastric Non Cardia Cancer; RR, Relative Risk; CI, Confidence Interval; CCHT, Changle County Helicobacter Trial; Hawaii DOH, Hawaii Department of Health Survey; HHP, Honolulu Heart Program; HERPACC, Hospital-based Epidemiologic Research Program at Aichi Cancer Center; JPHC, The Japan Public Health Center-based prospective Study; KMCC, Korean Multi-center Cancer Cohort; NIT, Linxian General Population Trial Cohort; RERF, Radiation Effects Research Foundation.
Figure 3Continuous dose-response association between pickled vegetable intake and risk of gastric cancer incidence with restricted cubic splines; The solid line represents the estimated relative risk, and the shaded area represents 95% confidence intervals.
Figure 4Study-specific and combined relative risks (95% confidence intervals) of gastric cancer incidence (b) per 60 g/day increment in salted fish intake and (a) comparing the highest to the lowest intake of salted fish; Abbreviation: GC, Gastric Cancer; RR, Relative Risk; CI, Confidence Interval; CCHT, Changle County Helicobacter Trial; FMCHES, Finnish Mobile Clinic Health Examination Survey; Hawaii DOH, Hawaii Department of Health Survey; HERPACC, Hospital-based Epidemiologic Research Program at Aichi Cancer Center; JPHC, The Japan Public Health Center-based prospective Study; KMCC, Korean Multi-center Cancer Cohort.
Stratified analysis of pickled vegetable or salted fish intake and overall gastric cancer risk (incidence and mortality combined).
| Subgroup | No. of Studies | RR (95% CI) | Q Test, | ||||
|---|---|---|---|---|---|---|---|
| Fixed-Effects | Random-Effects | ||||||
|
| |||||||
|
| |||||||
|
| 0.93 | ||||||
| Men | 6 | 1.00 (0.95, 1.05) | 1.04 (0.94, 1.15) | 0.19 | |||
| Women | 5 | 1.00 (0.94, 1.07) | 1.00 (0.94, 1.07) | 0.95 | |||
|
| 0.24 | ||||||
| Incidence | 6 | 1.15 (1.07, 1.23) | 1.13 (1.02, 1.25) | 0.14 | |||
| Mortality | 4 | 1.00 (0.96, 1.04) | 1.00 (0.96, 1.04) | 0.55 | |||
|
| 0.91 | ||||||
| Before 2000 | 4 | 1.10 (0.89, 1.36) | 1.10 (0.89, 1.36) | 0.47 | |||
| Since 2000 | 6 | 1.03 (1.00, 1.07) | 1.09 (0.99, 1.19) | 0.002 | |||
|
| 0.67 | ||||||
| <15 years | 9 | 1.03 (0.99, 1.06) | 1.08 (0.98, 1.19) | 0.01 | |||
| ≥15 years | 1 | 1.14 (1.00, 1.28) | 1.14 (1.00, 1.28) | - | |||
|
| 0.002 | ||||||
| Korea | 2 | 0.99 (0.95, 1.03) | 0.99 (0.95, 1.03) | 0.70 | |||
| Japan | 8 | 1.17 (1.10, 1.25) | 1.17 (1.10, 1.25) | 0.77 | |||
|
| |||||||
|
| 0.73 | ||||||
| Men | 8 | 1.10 (0.96, 1.27) | 1.10 (0.96, 1.27) | 0.64 | |||
| Women | 6 | 1.06 (0.85, 1.32) | 1.06 (0.85, 1.32) | 0.98 | |||
|
| 0.25 | ||||||
| Incidence | 8 | 1.19 (1.09, 1.31) | 1.24 (0.99, 1.55) | 0.001 | |||
| Mortality | 5 | 1.04 (0.90, 1.20) | 1.04 (0.90, 1.20) | 0.75 | |||
|
| 0.99 | ||||||
| Before 2000 | 4 | 1.14 (0.88, 1.47) | 1.14 (0.85, 1.52) | 0.33 | |||
| Since 2000 | 9 | 1.15 (1.06, 1.24) | 1.16 (0.97, 1.37) | 0.001 | |||
|
| 0.54 | ||||||
| <15 years | 10 | 1.22 (1.09, 1.37) | 1.18 (0.93, 1.50) | 0.001 | |||
| ≥15 years | 3 | 1.09 (0.99, 1.21) | 1.09 (0.99, 1.21) | 0.97 | |||
|
| 0.19 | ||||||
| Korea, China | 4 | 1.01 (0.86, 1.19) | 1.01 (0.86, 1.19) | 0.67 | |||
| Japan | 9 | 1.19 (1.09, 1.30) | 1.24 (1.02, 1.51) | 0.001 | |||
|
| |||||||
|
| |||||||
|
| 0.22 | ||||||
| Men | 4 | 1.21 (1.00, 1.45) | 1.21 (1.00, 1.45) | 0.97 | |||
| Women | 4 | 0.94 (0.70, 1.27) | 0.94 (0.70, 1.27) | 0.82 | |||
|
| 0.62 | ||||||
| Incidence | 2 | 1.15 (0.90, 1.48) | 1.15 (0.90, 1.48) | 0.50 | |||
| Mortality | 4 | 1.06 (0.89, 1.27) | 1.06 (0.89, 1.27) | 0.90 | |||
|
| - | ||||||
| Before 2000 | 0 | - | - | - | |||
| Since 2000 | 5 | 1.09 (0.94, 1.26) | 1.09 (0.94, 1.26) | 0.89 | |||
|
| - | ||||||
| <15 years | 5 | 1.09 (0.94, 1.26) | 1.09 (0.94, 1.26) | 0.89 | |||
| ≥15 years | 0 | - | - | - | |||
|
| 0.82 | ||||||
| Korea | 2 | 1.03 (0.66, 1.62) | 1.03 (0.66, 1.62) | 0.72 | |||
| Japan | 3 | 1.09 (0.94, 1.28) | 1.09 (0.94, 1.28) | 0.68 | |||
|
| |||||||
|
| 0.46 | ||||||
| Men | 7 | 1.10 (0.94, 1.28) | 1.12 (0.90, 1.39) | 0.15 | |||
| Women | 6 | 0.99 (0.79, 1.24) | 0.99 (0.79, 1.24) | 0.89 | |||
|
| 0.59 | ||||||
| Incidence | 6 | 1.17 (1.00, 1.38) | 1.13 (0.92, 1.39) | 0.25 | |||
| Mortality | 6 | 1.08 (0.94, 1.25) | 1.08 (0.94, 1.25) | 0.73 | |||
|
| 0.88 | ||||||
| Before 2000 | 4 | 1.05 (0.78, 1.42) | 1.06 (0.73, 1.54) | 0.21 | |||
| Since 2000 | 7 | 1.13 (1.01, 1.27) | 1.13 (1.01, 1.27) | 0.55 | |||
|
| 0.50 | ||||||
| <15 years | 8 | 1.11 (0.99, 1.24) | 1.10 (0.98, 1.25) | 0.38 | |||
| ≥15 years | 3 | 1.24 (0.86, 1.77) | 1.24 (0.86, 1.77) | 0.43 | |||
|
| 0.86 | ||||||
| Korea, China, Europe | 5 | 1.10 (0.90, 1.34) | 1.10 (0.90, 1.34) | 0.55 | |||
| Japan | 6 | 1.13 (0.99, 1.29) | 1.11 (0.95, 1.30) | 0.29 | |||
Abbreviations: RR, Relative Risk; CI, Confidence Interval.